Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Tran

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Annals of Clinical and Laboratory Science|October 19, 2022
Update: Correlation of Fentanyl Positive Drug Screens with other Medications in Patients from Pain, Rehabilitation and Behavioral ProgramsAmadeo Pesce, Keith Tran, Richard Thomas, et al.
Annals of Clinical and Laboratory Science|March 8, 2023
Changing Landscape of Fentanyl/Heroin Use and DistributionAmadeo Pesce, Nicholas Bevins, Keith Tran, et al.
Biomacromolecules|June 3, 2025
Transformation from Hydrophilic Yet Membrane-Inactive Linear Chain Polymers to Membrane-Active NanoantibioticsYunjiang Jiang, Wan Zheng, Keith Tran, et al.
Journal of Opioid Management|July 17, 2024
Observations on the effects of buprenorphine and methadone on illicit drug useAmadeo J Pesce, Keith Tran, Kevin Krock, et al.
Journal of Opioid Management|March 27, 2024
Monitoring buprenorphine in patients on medication-assisted treatmentAmadeo Pesce, Katie Bollman, Kevin Krock, et al.
Annals of Clinical and Laboratory Science|June 26, 2020
Reduction of Drug-Drug Interaction Risk; CDC Guidelines Influence on Opiate Benzodiazepine PrescribingAmadeo Pesce, Richard Thomas, Kevin Krock, et al.
Annals of Clinical and Laboratory Science|May 6, 2020
Correlation of Fentanyl Positive Drug Screens with Other Medications in Patients from Pain, Rehabilitation and Behavioral ProgramsKevin Krock, Joyce Nickley, Keith Tran, et al.
Nature Communications|January 12, 2022
Hydrophilic nanoparticles that kill bacteria while sparing mammalian cells reveal the antibiotic role of nanostructuresYunjiang Jiang, Wan Zheng, Keith Tran, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Annals of Clinical and Laboratory Science|October 19, 2022
Update: Correlation of Fentanyl Positive Drug Screens with other Medications in Patients from Pain, Rehabilitation and Behavioral ProgramsAmadeo Pesce, Keith Tran, Richard Thomas, et al.
Annals of Clinical and Laboratory Science|March 8, 2023
Changing Landscape of Fentanyl/Heroin Use and DistributionAmadeo Pesce, Nicholas Bevins, Keith Tran, et al.
Biomacromolecules|June 3, 2025
Transformation from Hydrophilic Yet Membrane-Inactive Linear Chain Polymers to Membrane-Active NanoantibioticsYunjiang Jiang, Wan Zheng, Keith Tran, et al.
Journal of Opioid Management|July 17, 2024
Observations on the effects of buprenorphine and methadone on illicit drug useAmadeo J Pesce, Keith Tran, Kevin Krock, et al.
Journal of Opioid Management|March 27, 2024
Monitoring buprenorphine in patients on medication-assisted treatmentAmadeo Pesce, Katie Bollman, Kevin Krock, et al.
Annals of Clinical and Laboratory Science|June 26, 2020
Reduction of Drug-Drug Interaction Risk; CDC Guidelines Influence on Opiate Benzodiazepine PrescribingAmadeo Pesce, Richard Thomas, Kevin Krock, et al.
Annals of Clinical and Laboratory Science|May 6, 2020
Correlation of Fentanyl Positive Drug Screens with Other Medications in Patients from Pain, Rehabilitation and Behavioral ProgramsKevin Krock, Joyce Nickley, Keith Tran, et al.
Nature Communications|January 12, 2022
Hydrophilic nanoparticles that kill bacteria while sparing mammalian cells reveal the antibiotic role of nanostructuresYunjiang Jiang, Wan Zheng, Keith Tran, et al.
Pageof 1